Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc.
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of AT-587 in Healthy Subjects | Digestive System Diseases, Infections, RNA Virus Infections, hepatitis, hepatitis E virus infection, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 1 | 2026-07-27 | NCT07728487 | |
| Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone | Healthy Volunteer Study | Recruiting | Phase 1 | 2026-07-16 | NCT07314346 | |
| C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV | Blood-Borne Infections, Chronic Disease, Digestive System Diseases, Disease Attributes, Flaviviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, chronic hepatitis C virus infection, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 3 | 2026-06-29 | NCT07037277 | |
| C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV | HEPATITIS C VIRUS CHRONIC INFECTION | Active, not recruiting | Phase 3 | 2025-12-05 | NCT06868264 |